November 29, 2016 - By Dolores Ford · 0 Comments
The stock of Conformis Incorporated (NASDAQ:CFMS) registered an increase of 14.03% in short interest. CFMS’s total short interest was 4.55 million shares in November as published by FINRA. Its up 14.03% from 3.99 million shares, reported previously. With 252,300 shares average volume, it will take short sellers 18 days to cover their CFMS’s short positions. The short interest to Conformis Incorporated’s float is 16.06%. About 79 shares traded hands. ConforMIS Inc (NASDAQ:CFMS) has declined 34.44% since April 26, 2016 and is downtrending. It has underperformed by 39.70% the S&P500.
ConforMIS, Inc. is a medical technology firm that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The company has a market cap of $370.07 million. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee. It currently has negative earnings. The Company’s iFit technology platform comprises three elements: iFit Design, iFit Printing and iFit Just-in-Time Delivery.
Out of 9 analysts covering ConforMIS Inc (NASDAQ:CFMS), 7 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 78% are positive. ConforMIS Inc has been the topic of 16 analyst reports since July 27, 2015 according to StockzIntelligence Inc. On Monday, July 27 the stock rating was initiated by Wells Fargo with “Outperform”. Wells Fargo downgraded the stock to “Market Perform” rating in Friday, May 13 report. The rating was maintained by Oppenheimer with “Outperform” on Tuesday, August 9. B. Riley & Co initiated ConforMIS Inc (NASDAQ:CFMS) rating on Friday, September 16. B. Riley & Co has “Buy” rating and $13 price target. The firm has “Overweight” rating given on Monday, July 27 by JP Morgan. The rating was maintained by Oppenheimer with “Outperform” on Wednesday, August 12. The firm has “Neutral” rating by JP Morgan given on Friday, May 13. The rating was initiated by Suntrust Robinson with “Buy” on Monday, September 19. The rating was maintained by Deutsche Bank on Friday, May 13 with “Buy”. JP Morgan maintained ConforMIS Inc (NASDAQ:CFMS) rating on Tuesday, August 9. JP Morgan has “Neutral” rating and $11 price target.
ConforMIS, Inc., incorporated on March 26, 2004, is a medical technology firm that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped. The Company’s products include iTotal, iTotal PS, iDuo and iUni. The Company’s iFit technology platform comprises three elements: iFit Design, iFit Printing and iFit Just-in-Time Delivery. iFit Design is the Company’s algorithms and computer software that it uses to design customized implants and associated single-use, patient-specific instrumentation, which is referred to as iJigs. iJigs is based on a computed tomography (CT) scan of the patient and to prepare a surgical plan customized for the patient that it calls iView. iFit Printing is a three-dimensional (3D) printing technology that the Company uses to manufacture iJigs. iFit Just-in-Time Delivery is its just-in-time manufacturing and delivery capability. The Firm markets and sells its products in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore and Hong Kong.
More notable recent ConforMIS Inc (NASDAQ:CFMS) news were published by: Marketwatch.com which released: “/quotes/zigman/3870025/realtime” on May 30, 2015, also Streetinsider.com with their article: “ConforMIS Inc (CFMS) Appoints New CEO” published on October 24, 2016, Quotes.Wsj.com published: “ConforMIS Inc. CFMS (US: Nasdaq)” on June 30, 2015. More interesting news about ConforMIS Inc (NASDAQ:CFMS) were released by: Marketwatch.com and their article: “Conformis shares plunge more than 30% on cut outlook, CEO search” published on May 12, 2016 as well as Globenewswire.com‘s news article titled: “ConforMIS Reports Fourth Quarter and Fiscal Year 2015 Financial Results …” with publication date: February 11, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Dolores Ford